Back to News
Market Impact: 0.25

SMCI Factor-Based Stock Analysis

SMCINDAQ
Company FundamentalsAnalyst InsightsTechnology & InnovationCorporate Earnings
SMCI Factor-Based Stock Analysis

Validea's guru fundamental report indicates that Super Micro Computer Inc. (SMCI) receives a 59% rating based on Warren Buffett's Patient Investor strategy, which favors firms with predictable profitability, low debt, and reasonable valuations; a score of 80% or higher suggests interest in the stock, while a score above 90% indicates strong interest. While SMCI passes tests for earnings predictability, debt service, initial rate of return, and expected return, it fails tests for return on equity, return on total capital, and free cash flow.

Analysis

Super Micro Computer Inc. (SMCI), a large-cap growth stock in the Computer Hardware industry, receives a 59% rating from Validea's Patient Investor model, which is based on Warren Buffett's investment strategy. This score falls below the 80% threshold typically indicating strategy interest and significantly below the 90% mark for strong interest. SMCI passes criteria for earnings predictability, debt service, use of retained earnings, initial rate of return, and expected return, suggesting some positive fundamental aspects. However, the company fails on crucial metrics such as return on equity, return on total capital, and free cash flow, which are key indicators of long-term profitability and efficiency often prioritized by Buffett's methodology. The share repurchase criterion is rated neutral. This mixed performance indicates that while certain aspects of SMCI's financial health align with the Patient Investor strategy, significant weaknesses in capital efficiency and cash generation detract from its overall appeal under this specific framework.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

NDAQ0.00
SMCI0.35

Key Decisions for Investors

  • Given SMCI's 59% rating and failures in key metrics like return on equity, return on total capital, and free cash flow, investors strictly adhering to Warren Buffett's Patient Investor criteria should approach with caution.
  • Further investigation is warranted into the reasons behind the low returns on capital and negative free cash flow, as these are significant concerns for long-term value creation.
  • While SMCI exhibits positive traits such as predictable earnings and manageable debt, the current assessment suggests it does not yet meet the high bar for a compelling investment under this specific value-oriented model, and its 'growth stock' label may require reconciliation with these fundamental shortcomings.